GEN-MKT-18-7897-A
Sep 13, 2018 | Blogs, Software, Technology | 0 comments
Advances in today’s technology have resulted in a need for higher and faster sample throughput, with increasing number of measured analytes per sample. The new SCIEX OS-MQ software breaks the routine and takes quantitation workflows to a new level.
Key features include:
Featuring a sleek, intuitive user interface combined with the peak integration algorithm, which allows you to automatically remove outliers from a calibration curve, and includes new tools for flagging and filtering results. Built from the software you already know and trust, these new features and more make data processing and review more streamlined and efficient than ever before, quick to learn and simple to master. The new SCIEX OS 1.4 was designed to support 21 CFR Part 11 Compliance, providing tools such as the incorporation of electronic audit trails, electronic signatures, and detailed security configurations. For those upgrading to SCIEX OS-MQ, a major benefit is the Explorer workspace, which provides the functionality for manual investigation of data similar to PeakView Software. With next-generation SCIEX OS-MQ software, you can be confident that you will achieve accurate and reliable results that address your laboratory requirements and increase overall laboratory productivity.
Read the latest tech note on how SCIEX is Improving Routine Quantitation Workflows in SCIEX OS-MQ.For more questions on upgrading, get in touch with a software specialist today >
Ultra‑low reporting limits, expanding target lists, and the constant risk of background contamination mean that even small missteps before injection can compromise data integrity. PFAS can be introduced at nearly every stage of prep, from sampling containers and PPE to SPE cartridges, filters, solvents, and lab consumables, making contamination control as critical as analyte recovery.
In monoclonal antibody (mAb) development, assessment of purity and integrity of the protein in question is critical. CE‑SDS is the gold standard assay and is routinely run from analytical development through QC and lot release. It’s trusted because it consistently delivers quantitative, size‑based insight into purity and fragmentation, and it fits naturally into regulated environments.
In drug discovery and development, Metabolite Identification (Met ID) plays a critical role in understanding biotransformation pathways, ensuring safety, and meeting regulatory requirements. Advanced mass spectrometry techniques have revolutionized this process, particularly through electron-based fragmentation methods such as Electron Activated Dissociation (EAD) and Electron Transfer Dissociation (ETD). While both techniques leverage electron interactions to generate informative fragment ions, they differ significantly in mechanism, performance, and suitability for Met ID workflows.
Posted by
You must be logged in to post a comment.
Share this post with your network